Search research articles
Contact Us
Filters
Showing results (11-20 of 214) with videos related to
Page
of 22
Sort By:
Drug Discovery Today
|
August 17, 2010
Fit-for-purpose biomarker method validation in anticancer drug development
Jeffrey Cummings, Tim H Ward, Caroline Dive
FEBS Letters
|
September 10, 2005
Comparison of phosphatidylinositol-3-kinase signalling within a panel of human colorectal cancer cell lines with mutant or wild-type PIK3CA
Christopher J Morrow, Alexander Gray, Caroline Dive
European Journal of Immunology
|
April 28, 2011
Medical societies unite to support research in Europe
, Ulf Smith, Karin Sipido, et al.
Cancer Cell
|
February 12, 2021
Small cell lung cancer enters the era of precision medicine
Kristopher K Frese, Kathryn L Simpson, Caroline Dive
Experimental Cell Research
|
April 10, 2012
Biomarkers of cell death applicable to early clinical trials
Emma Dean, Alastair Greystoke, Malcolm Ranson, et al.
Plos One
|
June 21, 2013
Hypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1Alpha
Jennifer Adamski, Andrew Price, Caroline Dive, et al.
Annual Review of Medicine
|
October 15, 2009
Biological mechanisms linking obesity and cancer risk: new perspectives
Darren L Roberts, Caroline Dive, Andrew G Renehan
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
December 9, 2008
Quantitative mass spectrometry-based techniques for clinical use: biomarker identification and quantification
Kathryn L Simpson, Anthony D Whetton, Caroline Dive
European Heart Journal
|
October 26, 2011
A new Alliance: biomedical societies in Europe unite to support research
Ulf Smith, Karin Sipido, Caroline Dive, et al.
EMBO Molecular Medicine
|
August 10, 2011
Alliance for biomedical research in Europe
Ulf Smith, Karin Sipido, Caroline Dive, et al.
Page
of 22
Search research articles
Search
Showing results (11-20 of 214) with videos related to
Sort By:
Page
of 22
Drug Discovery Today
|
August 17, 2010
Fit-for-purpose biomarker method validation in anticancer drug development
Jeffrey Cummings, Tim H Ward, Caroline Dive
FEBS Letters
|
September 10, 2005
Comparison of phosphatidylinositol-3-kinase signalling within a panel of human colorectal cancer cell lines with mutant or wild-type PIK3CA
Christopher J Morrow, Alexander Gray, Caroline Dive
European Journal of Immunology
|
April 28, 2011
Medical societies unite to support research in Europe
, Ulf Smith, Karin Sipido, et al.
Cancer Cell
|
February 12, 2021
Small cell lung cancer enters the era of precision medicine
Kristopher K Frese, Kathryn L Simpson, Caroline Dive
Experimental Cell Research
|
April 10, 2012
Biomarkers of cell death applicable to early clinical trials
Emma Dean, Alastair Greystoke, Malcolm Ranson, et al.
Plos One
|
June 21, 2013
Hypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1Alpha
Jennifer Adamski, Andrew Price, Caroline Dive, et al.
Annual Review of Medicine
|
October 15, 2009
Biological mechanisms linking obesity and cancer risk: new perspectives
Darren L Roberts, Caroline Dive, Andrew G Renehan
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
December 9, 2008
Quantitative mass spectrometry-based techniques for clinical use: biomarker identification and quantification
Kathryn L Simpson, Anthony D Whetton, Caroline Dive
European Heart Journal
|
October 26, 2011
A new Alliance: biomedical societies in Europe unite to support research
Ulf Smith, Karin Sipido, Caroline Dive, et al.
EMBO Molecular Medicine
|
August 10, 2011
Alliance for biomedical research in Europe
Ulf Smith, Karin Sipido, Caroline Dive, et al.
Page
of 22